Epazz Holdings' ZenaDrone Predictive Artificial Intelligence Sends the First Manufactured ZenaDrone 1000s for Drone as a Service in Ireland
CHICAGO, IL - (NewMediaWire) - October 03, 2023 - Epazz Inc. (OTC: EPAZ), a mission-critical provider of drone technology, artificial intelligence software, cryptocurrency apps, blockchain mobile apps and cloud-based business software solutions, has announced today that ZenaDrone is sending the first drones manufactured from the company’s new manufacturing facility to Ireland.
This is the first set of drones from 20 ZenaDrone 1000s that will be in service in Ireland to establish Drone as a Service (DaaS) operations. The company estimates that each deployed drone can generate over $100,000 per year.
ZenaDrone will work with Irish farmers to monitor plant health and spray weeds. Furthermore, the police force and fire departments will be able to mobilize the drones as an integrated part of the first-responder system.
About ZenaDrone (https://www.zenadrone.com/)
ZenaDrone is dedicated to improving intelligent UAV technology that incorporates machine-learning software and AI. It was created to revolutionize the hemp farming sector and later evolved into an intelligent multifunctional industrial surveillance, inspection and monitoring solution.
About Epazz Inc. (https://www.epazz.com/)
Epazz is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions and the public sector. Epazz BoxesOS™ v3.0 is a complete business web-based software package for small to midsized businesses, Fortune 500 enterprises, government agencies and higher education institutions. BoxesOS™ provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz’s other products are DeskFlex™ (room-scheduling software) and Provitrac™ (an applicant-tracking system).
The Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 reads as follows:
Certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of diction such as “may,” “expect,” “intend,” “estimate,” “anticipate,” “believe” and “continue” (or the negatives thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from future results or those implied by such statements. Investors are cautioned that any forward-looking statement does not guarantee future performance and that actual results may differ materially from those contemplated by such statements. Epazz Inc. assumes no obligation and has no intention of updating these forward-looking statements, and it has no obligation to update or correct information prepared by third parties that are not paid for by Epazz Inc. Investors are encouraged to review Epazz Inc.’s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC markets filings, which contain general business information about the company’s operations, results of operations and risks associated with the company and its operations.